Oncology

The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.

Latest News

t cells or cancer cells
Nivolumab-Chemotherapy Combination Lengthens Survival, Causes Manageable Adverse Effects in Stage III or IV Classic Hodgkin Lymphoma

October 17th 2024

Compared with brentuximab vedotin and chemotherapy, nivolumab and chemotherapy had longer progression-free survival and a better safety profile.

Sarcoma -- Image credit: Saiful52 | stock.adobe.com
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

October 17th 2024

Emerging HER2-Targeted Therapies in NSCLC: Zongertinib and BAY 2927088
Emerging HER2-Targeted Therapies in NSCLC: Zongertinib and BAY 2927088

October 17th 2024

Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer
Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer

October 17th 2024

CAR T-cell therapy is the use of genetically modified T cells that express a special protein called a chimeric antigen receptor 3d rendering
Loncastuximab Tesirine Demonstrates Promise in Managing Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-Cell Lymphoma

October 16th 2024

<1
...
218219220221222